Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor 7-like (TAF7L) is a transcription factor and component of the basal transcription factor TFIID complex required for transcription initiation by RNA polymerase II[1][4]. It is a testis-specific paralogue of TAF7, has a critical role in male germ cell development, and is necessary for normal sperm production and morphology[2]. TAF7L is also highly enriched in adipocytes and regulates the differentiation and function of white adipose tissue via mechanisms involving enhancer and promoter targeting with transcriptional coactivators such as PPARγ[3]. Mutations in the gene may result in male infertility, notably X-linked oligozoospermia[4]. It is under investigation as a cancer/testis antigen due to its testis-restricted expression, and its regulatory function in gene expression suggests possible roles in metabolic disease and cancer[3][4].
Not applicable for known drugs, but molecularly: inhibits TAF1 acetyltransferase activity, interacts with TBP, core transcriptional machinery, and enhancer-binding proteins like PPARγ[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 7-like (TAF7L).